312 related articles for article (PubMed ID: 17495324)
1. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.
Ding Q; He X; Xia W; Hsu JM; Chen CT; Li LY; Lee DF; Yang JY; Xie X; Liu JC; Hung MC
Cancer Res; 2007 May; 67(10):4564-71. PubMed ID: 17495324
[TBL] [Abstract][Full Text] [Related]
2. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization.
Ding Q; He X; Hsu JM; Xia W; Chen CT; Li LY; Lee DF; Liu JC; Zhong Q; Wang X; Hung MC
Mol Cell Biol; 2007 Jun; 27(11):4006-17. PubMed ID: 17387146
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.
Zhao Y; Altman BJ; Coloff JL; Herman CE; Jacobs SR; Wieman HL; Wofford JA; Dimascio LN; Ilkayeva O; Kelekar A; Reya T; Rathmell JC
Mol Cell Biol; 2007 Jun; 27(12):4328-39. PubMed ID: 17371841
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation.
Lee JY; Yu SJ; Park YG; Kim J; Sohn J
Mol Cell Biol; 2007 Apr; 27(8):3187-98. PubMed ID: 17283049
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
[TBL] [Abstract][Full Text] [Related]
7. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1.
Shinohara M; Ybanez MD; Win S; Than TA; Jain S; Gaarde WA; Han D; Kaplowitz N
J Biol Chem; 2010 Mar; 285(11):8244-55. PubMed ID: 20061376
[TBL] [Abstract][Full Text] [Related]
8. Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli.
Cheng YL; Huang WC; Chen CL; Tsai CC; Wang CY; Chiu WH; Chen YL; Lin YS; Chang CF; Lin CF
Biochem Biophys Res Commun; 2011 Aug; 412(2):334-40. PubMed ID: 21821001
[TBL] [Abstract][Full Text] [Related]
9. Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.
Song J; Chen Q; Xing D
Exp Cell Res; 2013 Jun; 319(10):1491-504. PubMed ID: 23524145
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of paclitaxel-induced breast cancer cell death via the glycogen synthase kinase-3β-mediated B-cell lymphoma 2 regulation.
Noh KT; Cha GS; Kang TH; Cho J; Jung ID; Kim KY; Ahn SC; You JC; Park YM
BMB Rep; 2016 Jan; 49(1):51-6. PubMed ID: 26246283
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological significance of GSK-3β inactivation in breast cancer-an immunohistochemical study.
Armanious H; Deschenes J; Gelebart P; Ghosh S; Mackey J; Lai R
Hum Pathol; 2010 Dec; 41(12):1657-63. PubMed ID: 20709358
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.
Hu Y; Dragowska WH; Wallis A; Duronio V; Mayer L
Breast Cancer Res Treat; 2001 Nov; 70(1):11-20. PubMed ID: 11767000
[TBL] [Abstract][Full Text] [Related]
13. Akt/protein kinase b and glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor.
Yoeli-Lerner M; Chin YR; Hansen CK; Toker A
Mol Cancer Res; 2009 Mar; 7(3):425-32. PubMed ID: 19258413
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3β inactivation is an intracellular marker and regulator for endotoxemic neutrophilia.
Yang TT; Chen CL; Lin WC; Lin YS; Tseng PC; Hsieh CY; Chen YH; Huang WC; Tsai CC; Wang CY; Shieh CC; Lin CF
J Mol Med (Berl); 2013 Feb; 91(2):207-17. PubMed ID: 22903504
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
18. Glycogen Synthase Kinase 3β Is Positively Regulated by Protein Kinase Cζ-Mediated Phosphorylation Induced by Wnt Agonists.
Tejeda-Muñoz N; González-Aguilar H; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
Mol Cell Biol; 2015 Dec; 36(5):731-41. PubMed ID: 26711256
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
20. Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
Kang XH; Zhang JH; Zhang QQ; Cui YH; Wang Y; Kou WZ; Miao ZH; Lu P; Wang LF; Xu ZY; Cao F
Cell Physiol Biochem; 2017; 41(5):2067-2076. PubMed ID: 28419994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
